Muscular Dystrophy

A Concise Guide

Raymond A. Huml (Herausgeber)

Buch | Softcover
XXIV, 191 Seiten
2015 | 1st ed. 2015
Springer International Publishing (Verlag)
978-3-319-17361-0 (ISBN)

Lese- und Medienproben

Muscular Dystrophy -
53,49 inkl. MwSt
This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.

Raymond A. Huml, MS, DVM, RAC, is Executive Director, Strategic Drug Development, in the Biosimilars Center of Excellence at Quintiles. He was recently the author of the SpringerBrief, Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional. He has recruited several prominent MD's to contribute chapters to Muscular Dystrophy: A Concise Guide.

1. Introduction to Muscular Dystrophy.- 2.Muscular Dystrophy: Historical Background and Types.- 3.FSHD: The Most Common Type of MD?.- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms.- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms.- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy.- 7.Overview of Current Treatments for Muscular Dystrophy.- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy.- 9.Orthopedic Care of Children with Muscular Dystrophy.- 10.Global Regulatory Landscape.- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy.- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy.- 13.US Patient Advocacy Groups.- 14.Global and National Patient Registries.- 15.Summary.- Index.

Erscheint lt. Verlag 30.7.2015
Zusatzinfo XXIV, 191 p. 43 illus., 30 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 413 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Schlagworte Early Stage Products, late stage products • Global and National Patient Registries • Mobility Assisted Devices, Patient Advocacy Groups • Muscular Dystrophy, Duchenne and Becker • pharmacotherapy • Regulatory Guidance, Physical Therapy
ISBN-10 3-319-17361-8 / 3319173618
ISBN-13 978-3-319-17361-0 / 9783319173610
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
97,00